Sign In
Buy ADPT
$22.57
-1.61 (-6.66%)
At Close: Jul 31, 2026
Adaptive Biotechnologies Reports First Quarter 2026 Financial Results
04:05pm, Tuesday, 05'th May 2026
SEATTLE, May 05, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the gene
Adaptive Biotechnologies' Chief Operating Officer Sold Over 19,000 Company Shares. Here's What That Means for Investors.
05:29pm, Monday, 04'th May 2026
This immune diagnostics innovator reported a notable insider sale as it advances platforms for disease detection and monitoring.
Adaptive Biotechnologies' COO Is Running a Systematic Sell Program — Here's What It Means
08:52am, Monday, 20'th Apr 2026
This immune diagnostics firm reported a notable insider sale as it expands its clinical portfolio and strategic partnerships.
Should You Sell Adaptive Biotechnologies (ADPT) After Its President and COO Sold 57,000 Shares?
10:37am, Saturday, 18'th Apr 2026
57,180 shares were sold for a total transaction value of approximately ~$826,000 across multiple days ending April 16, 2026. This sale represented 12.29% of Rubinstein's direct holdings at the time, r
Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026
04:05pm, Wednesday, 15'th Apr 2026
SEATTLE, April 15, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune sys
Julie Rubinstein Sells 19,060 Shares of Adaptive Biotechnologies (NASDAQ:ADPT) Stock
04:58am, Wednesday, 15'th Apr 2026
Adaptive Biotechnologies Corporation (NASDAQ: ADPT - Get Free Report) COO Julie Rubinstein sold 19,060 shares of the company's stock in a transaction that occurred on Monday, April 13th. The shares we
Adaptive Biotech Insider Sells $554K as Revenue Jumps 55%, but Here's What Investors Should Focus On
09:13am, Wednesday, 08'th Apr 2026
The President and COO of Adaptive Biotechnologies Corporation reported the sale of 38,120 shares for about $554,000, based on a weighted average transaction price of $14.53 per share across April 1–
JPMorgan Chase & Co. Sells 799,246 Shares of Adaptive Biotechnologies Corporation $ADPT
04:43am, Sunday, 05'th Apr 2026
JPMorgan Chase and Co. lowered its stake in shares of Adaptive Biotechnologies Corporation (NASDAQ: ADPT) by 77.2% in the third quarter, according to its most recent disclosure with the Securities and
Adaptive Biotech's President Trimmed Her Position. But what Remains is worth a look
08:08pm, Monday, 30'th Mar 2026
81,342 shares were sold for a total value of ~$1.21 million across multiple transactions from March 6 to March 10, 2026. The sale represented 11.22% of Rubinstein's direct holdings, reducing her direc
Adaptive Biotech Insider Sale of 180,000 Shares Tied to Tax Event as Stock Jumps 70% in a Year
12:13pm, Thursday, 26'th Mar 2026
An executive at Adaptive Biotechnologies reported the sale of 179,703 shares for about $2.37 million, based on a weighted average price of around $13.21 per share during March 11–13, 2026. This sale
Adaptive Biotechnologies Insider Sells $1 Million in Stock After a Doubling in Share Price
11:11am, Thursday, 26'th Mar 2026
Francis Lo, Chief People Officer at Adaptive Biotechnologies (ADPT +0.00%), reported the sale of a combined 68,667 shares of common stock across two transactions in early March 2026, as disclosed in a
Adaptive Biotechnologies (ADPT) Moves 5.8% Higher: Will This Strength Last?
08:16am, Monday, 16'th Mar 2026
Adaptive Biotechnologies (ADPT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further stre
Adaptive Biotechnologies Corporation $ADPT Position Lowered by Cinctive Capital Management LP
05:36am, Monday, 16'th Mar 2026
Cinctive Capital Management LP trimmed its position in Adaptive Biotechnologies Corporation (NASDAQ: ADPT) by 49.6% in the third quarter, according to its most recent disclosure with the SEC. The inst
Adaptive Biotechnologies (NASDAQ:ADPT) COO Sells $1,881,638.07 in Stock
04:21am, Monday, 16'th Mar 2026
Adaptive Biotechnologies Corporation (NASDAQ: ADPT - Get Free Report) COO Julie Rubinstein sold 141,583 shares of the firm's stock in a transaction dated Wednesday, March 11th. The stock was sold at a
Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) Insider Sells $6,193,403.22 in Stock
04:21am, Monday, 16'th Mar 2026
Adaptive Biotechnologies Corporation (NASDAQ: ADPT - Get Free Report) insider Harlan Robins sold 470,266 shares of Adaptive Biotechnologies stock in a transaction dated Wednesday, March 11th. The stoc
